Predictors of Immunological Failure after Initial Response to Highly Active Antiretroviral Therapy in HIV‐1–Infected Adults: A EuroSIDA Study

Ulrik Bak Dragsted, Amanda Mocroft, Stefano Vella, Jean‐Paul Viard, Ann‐Brit Eg Hansen, George Panos, D Mercey, Ladislav Machala, Andrzej Horban, Jens Lundgren

The Journal of Infectious Diseases · 2004 · 63 citations · 23 references

DOIFull text

Open access

Abstract

The risk of immunological failure in patients with an immunological response to HAART diminishes with a longer time receiving treatment and is associated with pretreatment CD4(+) cell count, ongoing viral replication, and intravenous drug use.

References

23